Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our customタンパク質 services!
カスタムサービスについてのお問い合わせはこちら >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
| NCE for the treatment of IPF | Small molecule | Respiratory disease | IPF | Phase II | Global (except China) |
GMP Human TNF-alpha Protein (Cat. No. GMP-TNAH23) induces cytotoxicity effect on the WEHI-13VAR cells in the presence of the metabolic inhibitor actinomycin D. The specific activity GMP Human TNF-alpha Protein (Cat. No. GMP-TNAH23) is ≥ 2.00×10^7 IU/mg, which is calibrated against human TNF-alpha WHO International Standard (NIBSC code: 12/154) (QC tested).
Biotinylated Monoclonal Anti-TNF-alpha Antibody, human IgG1 (16H5) (Cat. No. TNA-BLM494) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human TNF-alpha, His Tag (Cat. No. TNA-H5228) with an affinity constant of 75.9 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Monoclonal Anti-TNF-alpha antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human TNF-alpha, His Tag (Cat. No. TNA-H5228) with an affinity constant of 0.133 nM as determined in a SPR assay (Biacore 8K) (Routly tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Etanercept biosimilar (Hisun-Pfizer Pharmaceuticals) | Approved | Hisun-Pfizer | AnBaiNuo | Mainland China | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Wyeth Europa Ltd | 2010-02-26 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic | Details | |
| Infliximab biosimilar (Bionovis/The Instituto Vital Brazil) | Approved | Bionovis, The Instituto Vital Brazil | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease | Details | ||||||
| Etanercept biosimilar (Intas Biopharmaceuticals) | Approved | Intas Biopharmaceuticals | Intacept | India | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Psoriasis | Intas Biopharmaceuticals | 2015-03-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details | |
| Anti-tumour necrosis factor-alpha antibody | Approved | Materia Medica Holding Research And Production Company | Artrofoon, Arthrofoon | Arthritis, Rheumatoid; Osteoarthritis | Details | |||||
| Etanercept biosimilar (AryoGen Biopharma) | Approved | Aryogen Biopharma | Altebrel | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details | |||||
| Etanercept biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Nanercept | Vietnam | Psoriasis; Arthritis, Rheumatoid | Nanogen Biopharmaceutical Co | 2019-01-01 | Arthritis, Rheumatoid; Psoriasis | Details | |
| Etanercept biosimilar (PROBIOMED) | Approved | Probiomed | Infinitam | Mexico | Arthritis, Rheumatoid | Probiomed | 2014-01-01 | Arthritis, Rheumatoid | Details | |
| Adalimumab biosimilar (Reliance Life Sciences) | R-TPR-021 | Approved | Reliance Life Sciences | Adfrar IB | India | Colitis, Ulcerative; Psoriasis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic | Reliance Life Sciences, Torrent Pharma | 2016-01-12 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic | Details |
| Infliximab biosimilar (AXXO) | Approved | Axxo | Russian Federation | Crohn Disease; Autoimmune Diseases | Axxo | 2013-01-01 | Autoimmune Diseases; Crohn Disease | Details | ||
| Etanercept biosimilar (Mochida) | LBEC-0101 | Approved | Mochida Pharmaceutical Co Ltd | Japan | Arthritis, Juvenile; Arthritis, Rheumatoid | null | 2018-01-19 | Arthritis, Rheumatoid; Arthritis, Juvenile | Details | |
| Etanercept biosimilar (Amega Biotech) | Approved | Amega Biotech | Enerceptan | Argentina | Arthritis, Rheumatoid | Amega Biotech | 2012-01-01 | Arthritis, Rheumatoid | Details | |
| Etanercept biosimilar (Mylan) | YLB-113 | Approved | Rubin Ltd, Mylan Nv | Nepexto | EU | Arthritis, Rheumatoid; Spondylarthropathies; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Plaque psoriasis | Mylan Ire Healthcare Ltd | 2020-05-20 | Arthritis, Rheumatoid; Spondylarthropathies; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Psoriatic; Plaque psoriasis | Details |
| Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Shanghai Cp Guojian) | Approved | Shanghai Cp Guojian Pharmaceutical Co Ltd | 益赛普 | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details | |||||
| Adalimumab biosimilar (CTTQ Pharma) | Approved | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Mainland China | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 2022-01-18 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease | Details | ||
| Adalimumab biosimilar (Zydus Cadila) | ZRC-3197 | Approved | Zydus Cadila | Exemptia, Adaly | India | Arthritis, Juvenile; Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing | Zydus Cadila | 2014-12-09 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Psoriatic | Details |
| Adalimumab biosimilar (Hisun Pharma) | HS-016 | Approved | Zhejiang Hisun Pharmaceutical Co Ltd | 安健宁 | Mainland China | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Hisun Biopharmaceutical Co Ltd | 2019-12-06 | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
| Infliximab biosimilar (Hisun Pharma) | HS-626 | Approved | Zhejiang Hisun Pharmaceutical Co Ltd | Mainland China | Psoriasis | Hisun Biopharmaceutical Co Ltd | 2021-09-24 | Psoriasis | Details | |
| Adalimumab biosimilar (Coherus BioSciences) | CHS-1420 | Approved | Coherus Biosciences Inc | Yusimry | United States | Colitis, Ulcerative; Plaque psoriasis; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Crohn Disease | Coherus Biosciences Inc | 2021-12-17 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis; Crohn Disease | Details |
| PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis | Details |
| Adalimumab biosimilar (Biocad) | BCD-057 | Approved | Biocad | Russian Federation | Psoriasis | Biocad | 2019-03-01 | Psoriasis | Details | |
| Adalimumab biosimilar (Bio-Thera Solutions) | BAT-1406 | Approved | Bio-Thera Solutions Ltd | 格乐立 | Mainland China | Psoriasis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Crohn Disease; Uveitis | Bio-Thera Solutions Ltd | 2019-11-04 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Uveitis; Crohn Disease | Details |
| Adalimumab biosimilar (Innovent Biologics) | IBI-303 | Approved | Innovent Biologics(Suzhou) Co Ltd | 苏立信 | Mainland China | Crohn Disease; Pediatric Crohn's disease | Innovent Biologics(Suzhou) Co Ltd | 2020-09-02 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Uveitis; Plaque psoriasis; Crohn Disease | Details |
| Luminol sodium | MP-1032 | Approved | Selvim, Metrio | Psoriasis; Immune System Diseases | null | 1997-01-01 | Immune System Diseases; Psoriasis | Details | ||
| Adalimumab biosimilar (Boehringer Ingelheim) | BI-695501 | Approved | C.H. Boehringer Sohn Ag & Co. Kg | Cyltezo | United States | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis | Boehringer Ingelheim Gmbh | 2017-08-25 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Uveitis; Hidradenitis Suppurativa; Crohn Disease | Details |
| Infliximab biosimilar (Amgen) | ABP-710 | Approved | Amgen Inc | Avsola | United States | Plaque psoriasis; Pediatric ulcerative colitis; Pediatric Crohn's disease; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease | Amgen Inc | 2019-12-06 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric ulcerative colitis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease | Details |
| Etanercept biosimial (Sandoz) | GP-2015 | Approved | Clariant Produkte (Schweiz) Ag | Erelzi | EU | Arthritis, Juvenile; Plaque psoriasis; Spondylitis, Ankylosing; Arthritis, Psoriatic; Arthritis, Rheumatoid | Sandoz Gmbh | 2016-08-30 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Plaque psoriasis | Details |
| Adalimumab biosimilar (Amgen) | ABP-501 | Approved | Amgen Inc | Amgevita, Amjevita, Solymbic | EU | Amgen Europe Bv | 2016-09-23 | Non-radiographic axial spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Uveitis; Crohn Disease; Plaque psoriasis | Details | |
| Infliximab Biosimilar (Genor Biopharma) | GB-242 | Approved | Genor Biopharma Co Ltd | 佳佑健 | Mainland China | Spondylitis, Ankylosing; Crohn Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Rheumatoid | Yuxi Genor Biotechnology Co Ltd | 2022-02-23 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Crohn Disease | Details |
| Etanercept biosimilar (Hanwha Chemical) | HD-203; MK-8953 | Approved | Hanwha Chemical | Davictrel | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic | Details | ||||
| Infliximab biosimilar (Nichiiko/Aprogen) | NI-071; GS-071; GS-07; AP-07 | Approved | Nichi-Iko Pharmaceutical Co Ltd, Aprogen | Japan | Arthritis, Psoriatic; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis | Nichi-Iko Pharmaceutical Co Ltd | 2017-09-27 | Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease | Details | |
| Opinercept | E-11; ENIA-11 | Approved | Tsh Biopharm, Mycenax Biotech Inc | TuNEX | Taiwan | Arthritis, Rheumatoid | null | 2017-01-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
| Adalimumab biosimilar (Fujifilm Kyowa Kirin Biologics/Mylan) | FKB-327 | Approved | Fujifilm Kyowa Kirin Biologics Co Ltd | Hulio | EU | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Uveitis; Hidradenitis Suppurativa; Arthritis, Psoriatic | Viatris Ltd | 2018-09-16 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis; Hidradenitis Suppurativa; Crohn Disease | Details |
| Adalimumab biosimilar (Mylan/Biocon) | BMO-2; MYL-1401-A | Approved | Biocon Ltd | United States | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis | Mylan Pharmaceuticals Inc | 2020-07-06 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis | Details | |
| Adalimumab biosimilar (Celltrion) | CT-P17 | Approved | Celltrion Inc | Yuflyma | EU | Arthritis, Rheumatoid; Colitis, Ulcerative; Hidradenitis Suppurativa; Psoriasis; Spondylitis, Ankylosing; Pediatric ulcerative colitis; Pediatric Crohn's disease; Arthritis, Juvenile; Plaque psoriasis; Crohn Disease; Uveitis; Arthritis, Psoriatic | Celltrion Healthcare Hungary Kft | 2021-02-11 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Juvenile; Psoriasis; Pediatric ulcerative colitis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Plaque psoriasis; Crohn Disease | Details |
| Infliximab | TA-650 | Approved | Janssen Global Services Llc | Remicade, 类克, Avakine, CenTNF | EU | Psoriasis | Janssen Biologics Bv | 1998-08-24 | Parapsoriasis; Diabetic macular oedema; Psoriasis; Pediatric ulcerative colitis; Vitreoretinopathy, Proliferative; Glaucoma; Arthritis, Psoriatic; Colitis, Ulcerative; Aneurysm; Retinal Detachment; Visual Acuity; Uveitis; Hidradenitis Suppurativa; Granulomatous Disease, Chronic; Pulmonary Disease, Chronic Obstructive; Crohn Disease; Stevens-Johnson Syndrome; Behcet Syndrome; Diabetic Retinopathy; Melanoma; Spondylarthropathies; Inflammatory Bowel Diseases; Pancreatitis; Scleritis; Giant Cell Arteritis; Dermatomyositis; Pediatric Crohn's disease; Vasculitis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Polymyositis; Graft vs Host Disease; Bipolar Disorder; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Mucocutaneous Lymph Node Syndrome; Stroke; Polymyalgia Rheumatica; Arthritis, Juvenile | Details |
| Edaravone/(+)-2-Decanol | SIM-071201; Y-2 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Intracranial Hemorrhages; Cerebral Hemorrhage; Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis | Details | |
| Adalimumab biosimilar (Pfizer) | PF-06410293 | Approved | Pfizer Pharmaceuticals Ltd (China) | Amsparity, Abrilada, Fyzoclad | EU | Arthritis, Psoriatic; Hidradenitis Suppurativa; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Uveitis; Psoriasis | Pfizer Europe Ma Eeig | 2019-11-15 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Uveitis; Crohn Disease | Details |
| Pomalidomide | IMID-4047; CDC-394; CC-4047; IMiD-1 | Approved | Celgene Corp | Pomalyst, Imnovid, Actimid, Pomalyst/Imnovid, 安跃 | Mainland China | Multiple Myeloma | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 2013-02-08 | Pulmonary Fibrosis; Anemia, Sickle Cell; Atypical Squamous Cells of the Cervix; Neurofibromatosis 1; Sarcoma, Kaposi; Lymphoma, Non-Hodgkin; Carcinoma, Small Cell; Glioma; Waldenstrom Macroglobulinemia; Primary Myelofibrosis; Sarcoma; Prostatic Neoplasms; Thrombocytosis; Lung Diseases, Interstitial; Solid tumours; Central Nervous System Neoplasms; Multiple Myeloma; Hodgkin Disease; Scleroderma, Systemic; Pancreatic Neoplasms; Kidney Diseases; Immunoglobulin Light-chain Amyloidosis; Graft vs Host Disease; Myeloproliferative Disorders; Plasmacytoma; Polycythemia Vera; Medulloblastoma; Bone Marrow Neoplasms | Details |
| Adalimumab biosimilar (LG Life Sciences) | LBAL | Approved | Lg Chemical Ltd, Mochida Pharmaceutical Co Ltd | Japan | Behcet Syndrome; Uveitis, Intermediate; Uveitis, Posterior; Panuveitis; Crohn Disease; Colitis, Ulcerative; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Arthritis, Juvenile | Mochida Pharmaceutical Co Ltd | 2021-03-23 | Uveitis, Intermediate; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis, Posterior; Behcet Syndrome; Panuveitis; Crohn Disease | Details | |
| Lenalidomide | CC-5013; IMiD-3; ENMD-0997; STAR-LLD; CDC-501; IMID-5013; CDC-5013 | Approved | Celgene Corp | Revimid (former Brand Name), 瑞复美, Revlimid, Leavdo | EU | Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular | Celgene Europe Bv | 2005-12-27 | Leukemia; Leukemia, Myeloid; Immunoproliferative Small Intestinal Disease; Leukemia, Erythroblastic, Acute; Lymphoma, T-Cell, Peripheral; Lymphoma, B-Cell, Marginal Zone; Ovarian Neoplasms; Medulloblastoma; Intestinal Neoplasms; Bone Marrow Neoplasms; Solid tumours; Kidney Neoplasms; Liver Neoplasms; HIV Infections; Hematologic Diseases; Optic Nerve Glioma; Leukemia, Promyelocytic, Acute; Ependymoma; Anemia, Refractory, with Excess of Blasts; Plaque, Amyloid; Leukemia, Hairy Cell; Anemia; Paraproteinemias; Pain; Polycythemia Vera; Rhabdoid Tumor; Hodgkin Disease; Myelodysplastic Syndromes; Nerve Degeneration; Lymphomatoid Granulomatosis; Pancreatic Neoplasms; Smoldering Multiple Myeloma; Anemia, Refractory; Leukemia-Lymphoma, Adult T-Cell; Plasmacytoma; Lymphoma, Large B-Cell, Diffuse; Blood Protein Disorders; Neoplasms; Glioblastoma; Leukemia, Myelomonocytic, Chronic; Graft vs Host Disease; Hypothalamic Neoplasms; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Acute; Urinary Bladder Neoplasms; Multi | Details |
| Certolizumab pegol | PHA-738144; CDP-870; CZP | Approved | Ucb | Cimzia, Cimziat | Mainland China | Arthritis, Rheumatoid | Ucb Pharma Sa | 2008-04-22 | Infertility, Male; Polyarticular Juvenile Idiopathic Arthritis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Spondylarthropathies; Spondylarthritis; Psoriasis; Cystitis, Interstitial; Colitis, Ulcerative; Arthritis, Psoriatic; Osteoarthritis, Spine; Crohn Disease; Plaque psoriasis | Details |
| Adalimumab biosimilar (Jiangsu Zhonghe/Shanghai Junshi/Jiangsu T-Mab) | UBP-1211; 9MW0113; 9-MW-0113; 9-MW0113; 9MW-0113 | Approved | Shanghai Junshi Biosciences Co Ltd, Jiangsu Zhonghe Pharmaceutical Technology Co Ltd, Jiangsu T-Mab Bio-Pharmaceuticals Co Ltd, Mabwell (Shanghai) Bioscience Co Ltd | 君迈康 | Mainland China | Crohn Disease; Pediatric Crohn's disease; Uveitis; Arthritis, Juvenile | Shanghai Junshi Biosciences Co Ltd | 2022-03-01 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Juvenile; Psoriasis; Uveitis; Crohn Disease | Details |
| Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Japan | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | Osteosarcoma; Leprosy, Lepromatous; Drug Resistant Epilepsy; Primary Myelofibrosis; Neuroectodermal Tumors, Primitive; Prostatitis; Colorectal Neoplasms; Lymphoma, Mantle-Cell; Sarcoma, Ewing; Retinoblastoma; Waldenstrom Macroglobulinemia; Cholangitis, Sclerosing; HIV Wasting Syndrome; Arachnoiditis; Adenocarcinoma, Clear Cell; Prostatic Neoplasms; Pancreatitis, Chronic; Lymphoma, Follicular; Sarcoma; Xerostomia; Burning Mouth Syndrome; Neoplasm Metastasis; Mycobacterium avium-intracellulare Infection; Vascular Malformations; Amyotrophic Lateral Sclerosis; Melanoma; Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Stomatitis; Erythema Nodosum; Anemia, Sideroblastic; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Glioma; Angiodysplasia; Pelvic Pain; Appendiceal Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Mycobacterium Infections; Gastric Antral Vascular Ectasia; Carcinoid Tumor; Lupus Erythematosus, Discoid; Stomatitis, Aphthous; Rhabdomyosarcoma; | Details |
| Golimumab | CNTO-148; rTNV148B | Approved | Janssen Global Services Llc | Simponi, Simponi aria, Simponi/Simponi aria | Mainland China | Arthritis, Rheumatoid; Spondylitis, Ankylosing | Janssen Biologics Bv | 2009-04-24 | Diabetes Mellitus, Type 1; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Colitis, Ulcerative; Arthritis, Psoriatic; Asthma; Crohn Disease; Labyrinth Diseases | Details |
| Etanercept biosimilar (Samsung Bioepis) | SB-4 | Approved | Samsung Bioepis Co Ltd | Eticovo, Benepali | United States | Arthritis, Juvenile; Arthritis, Rheumatoid; Psoriasis; Spondylitis, Ankylosing; Arthritis, Psoriatic | Samsung Bioepis Co Ltd | 2016-01-13 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details |
| Etanercept | TNR-001 | Approved | Pfizer Pharmaceuticals Ltd (China), Amgen Inc | 恩利, Enbrel, Lifmior | Mainland China | Psoriasis; Spondylitis, Ankylosing; Arthritis, Rheumatoid | C.H. Boehringer Sohn Ag & Co. Kg | 1998-11-02 | Cachexia; Psoriasis; Myositis, Inclusion Body; Prostatic Neoplasms; Asthma; Alzheimer Disease; Arthritis, Psoriatic; Lichen Planus; Bone Neoplasms; Inflammation; Uveitis; Respiratory Distress Syndrome, Adult; Arthritis; Obesity; Hidradenitis Suppurativa; Lung Neoplasms; Stomatitis; Plaque psoriasis; Neoplasm Metastasis; Acute Lung Injury; Kidney Failure, Chronic; Vitiligo; Lupus Erythematosus, Cutaneous; Diabetes Mellitus, Type 1; HIV Infections; Tinnitus; Solid tumours; Bronchiolitis Obliterans; Leukemia; Lupus Erythematosus, Discoid; Arthritis, Rheumatoid; Metabolic Syndrome; Vasculitis; Granulomatosis with Polyangiitis; Spondylarthritis; Spondylitis, Ankylosing; Synovitis; Sjogren's Syndrome; Chronic Urticaria; Anorexia; Fanconi Anemia; Graft vs Host Disease; Arthritis, Juvenile; Pulmonary Fibrosis | Details |
| Adalimumab | ABT-D2E7; LU-200134; D2E7 | Approved | Abbvie Inc | Humira, Trudexa, 修美乐 | EU | Colitis, Ulcerative; Uveitis; Psoriasis; Hidradenitis Suppurativa | Stada Arzneimittel Ag | 2002-12-31 | Uveitis, Posterior; Colitis, Ulcerative; Cystitis, Interstitial; Arthritis, Psoriatic; Osteoarthritis, Knee; Asthma; Hidradenitis Suppurativa; Uveitis; Arthritis; Glomerulosclerosis, Focal Segmental; Mucopolysaccharidosis II; Nephrotic Syndrome; Osteoarthritis; Crohn Disease; Plaque psoriasis; Diabetic Retinopathy; Choroidal Neovascularization; Panuveitis; Pouchitis; Pyoderma Gangrenosum; Pain; Uveitis, Intermediate; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric Crohn's disease; Spondylarthritis; Sarcoidosis; Bursitis; Coronavirus Disease 2019 (COVID-19); Arthritis, Juvenile; Mucopolysaccharidosis I; Nephrosis, Lipoid; Dupuytren Contracture; Psoriasis; Mucopolysaccharidosis VI | Details |
| Infliximab biosimilar (Merck & Co/Samsung Bioepis) | SB-2 | Approved | Samsung Bioepis Co Ltd, Merck & Co Inc | Renflexis, Flixabi | United States | Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid | Samsung Bioepis Co Ltd | 2016-05-26 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease | Details |
| Ozoralizumab | PF-5230896; PF-05230896; TS-152; ATN-103 | Approved | Ablynx Nv | Japan | Arthritis, Rheumatoid | Taisho Pharmaceutical Co Ltd | 2022-09-26 | Arthritis, Rheumatoid | Details | |
| Infliximab biosimilar (Celltrion) | CT-P13 | Approved | Celltrion Inc | Remsima, Inflectra, Inflectra/Remsima, Flammegis | Japan | Arthritis, Psoriatic; Arthritis, Rheumatoid; Crohn Disease; Psoriasis; Colitis, Ulcerative | Celltrion Inc | 2013-09-10 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Urologic Neoplasms; Crohn Disease | Details |
| Adalimumab biosimilar (Sandoz) | GP-2017 | Approved | Sandoz | Hefiya, Hyrimoz, Halimatoz | United States | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis | Sandoz Inc | 2018-07-26 | Non-radiographic axial spondyloarthritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Uveitis; Hidradenitis Suppurativa; Plaque psoriasis; Crohn Disease | Details |
| Etanercept biosimilar (Shanghai CP Guojian Pharmaceutical) | 301S | Approved | Shanghai Cp Guojian Pharmaceutical Co Ltd, Cipla Gmbh | Yisaipu, Etacept, 益赛普, Etanar | Mainland China | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis | Shanghai Cp Guojian Pharmaceutical Co Ltd | 2005-06-20 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis | Details |
| Adalimumab biosimilar (Samsung Bioepis) | SB-5 | Approved | Samsung Bioepis Co Ltd | Imraldi, Hadlima | United States | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Psoriasis | Samsung Bioepis Co Ltd | 2017-08-24 | Pediatric Crohn's disease; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Pediatric ulcerative colitis; Arthritis, Psoriatic; Colitis, Ulcerative; Uveitis; Hidradenitis Suppurativa; Plaque psoriasis; Crohn Disease | Details |
| Infliximab biosimilar (Shanghai Biomabs) | CMAB-008; STI-002 | Approved | Shanghai Biomabs Pharmaceuticals Co Ltd | 百类停, 类停 | Mainland China | Pediatric Crohn's disease; Crohn Disease; Spondylitis, Ankylosing; Colitis, Ulcerative; Psoriasis; Arthritis, Rheumatoid | Taizhou Mabtech Pharmaceutical Co Ltd | 2021-07-12 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Crohn Disease | Details |
| Adalimumab biosimilar (Shanghai Henlius Biotech) | HLX-03 | Approved | Shanghai Henlius Biotech Co Ltd | 汉达远 | Mainland China | Uveitis, Intermediate; Uveitis, Posterior; Panuveitis | Shanghai Henlius Biotech Co Ltd | 2020-12-02 | Uveitis, Intermediate; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Immune System Diseases; Psoriasis; Uveitis, Posterior; Plaque psoriasis; Panuveitis | Details |
| Infliximab biosimilar (Pfizer) | PF-6438179; GP-1111; PF-06438179 | Approved | Pfizer Inc | Ixifi, Zessly | Japan | Colitis, Ulcerative; Crohn Disease; Psoriasis; Arthritis, Rheumatoid; Arthritis, Psoriatic | Pfizer Inc | 2013-09-09 | Pediatric Crohn's disease; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Pediatric ulcerative colitis; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Crohn Disease | Details |
| Infliximab biosimilar (Reliance Life Sciences) | BOW-015; R-TPR-015 | Approved | Epirus Biopharmaceuticals Inc | Infimab | Arthritis, Rheumatoid | Details | ||||
| Adalimumab biosimilar (Fresenius Kabi) | MSB-11022 | Approved | Merck Serono, Fresenius Kabi Ag | Idacio, Kromeya | EU | Colitis, Ulcerative; Psoriasis; Hidradenitis Suppurativa | Fresenius Kabi Deutschland Gmbh | 2019-04-02 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Uveitis; Hidradenitis Suppurativa; Crohn Disease | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Adalimumab biosimilar (CinnaGen) | Phase 3 Clinical | Cinnagen | Arthritis, Rheumatoid | Details | |
| Recombinant human anti-TNFα monoclonal antibody (Huaota Biopharma) | Phase 3 Clinical | Shanghai Huaota Biopharmaceutical Co Ltd | Spondylitis, Ankylosing; Psoriasis; Arthritis; Plaque psoriasis | Details | |
| Adalimumab biosimilar (AXXO) | Clinical | Axxo | Arthritis, Rheumatoid; Arthritis, Psoriatic | Details | |
| IBPM005IX (Inbiopro Solutions) | Clinical | Inbiopro Solutions | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Arthritis, Psoriatic; Crohn Disease | Details | |
| Etanercept (Neurokine Pharmaceuticals) | NP-1; NK-001 | Clinical | Pivot Pharmaceuticals | Cognition Disorders | Details |
| Anti-tumour necrosis factor alpha (Livzon) | Phase 1 Clinical | Livzon Pharmaceutical Group Inc | Autoimmune Diseases | Details | |
| Adalimumab biosimilar (Danhong Pharma) | BC-002 | Phase 3 Clinical | Shandong Danhong Pharmaceutical Co Ltd | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
| Adalimumab biosimilar (Tonghua Dongbao Pharmaceutical) | Phase 3 Clinical | Tonghua Dongbao Pharmaceutical Co Ltd | Arthritis, Rheumatoid; Plaque psoriasis | Details | |
| Recombinant anti-TNFα monoclonal antibody (Wuhan Institute of Biological Products) | Phase 3 Clinical | Wuhan Institute Of Biological Products Co Ltd | Plaque psoriasis | Details | |
| JNJ-63823539 | JNJ-63823539 | Phase 1 Clinical | Janssen Global Services Llc | Arthritis, Rheumatoid | Details |
| SAR-442970 | SAR-442970 | Phase 1 Clinical | Sanofi | Inflammation | Details |
| Adalimumab biosimilar (Weimingdamu Biotech) | Phase 1 Clinical | Anhui Weiming Damu Biomedicine Co Ltd | Arthritis, Rheumatoid | Details | |
| Adalimumab biosimilar(BioXpress) | BX-2922; BXT-2922 | Clinical | Bioxpress Therapeutics Sa | Spondylitis, Ankylosing; Pediatric Crohn's disease; Arthritis, Rheumatoid; Arthritis, Juvenile; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis; Hidradenitis Suppurativa; Crohn Disease | Details |
| Adalimumab biosimillar(Huabo) | Onco-3010; HOT-3010 | Phase 3 Clinical | Huabo Biopharm Co Ltd | Arthritis, Rheumatoid | Details |
| Infliximab biosimilar (Ospedale San Raffaele) | Phase 1 Clinical | Ospedale San Raffaele | Takayasu Arteritis | Details | |
| Recombinant anti-TNFα monoclonal antibody (Livzon Group) | AT-132; LZM-001 | Phase 2 Clinical | Livzon Pharmaceutical Group Inc | Arthritis, Rheumatoid | Details |
| Wogonin | Phase 1 Clinical | Shandong Buchang Pharmaceuticals Co Ltd, Hefei Cosource Medicine Technology, Daewoong Pharmaceutical Co Ltd, China Pharmaceutical University | Respiratory Tract Infections; Neoplasms | Details | |
| HMPL-004 (Hutchison Medipharma) | HMPL-004 | Details | |||
| Infliximab biosimilar (Biocad) | BCD-055 | Biocad | Details | ||
| Tumour necrosis factor alpha kinoid | TNF-K; TNF-K005 | Neovacs | Details | ||
| ME-3183 | ME-3183 | Phase 1 Clinical | Meiji Seika Pharma Co Ltd | Psoriasis | Details |
| JNJ-61178104 | JNJ-61178104 | Phase 1 Clinical | Janssen Global Services Llc | Autoimmune Diseases | Details |
| Etanercept biosimilar (Coherus Biosciences) | CHS-0214; BAX-2200 | Coherus Biosciences Inc | Details | ||
| Doramapimod | BIRB-796-BS; BIRB-0796; BIRB-796; BIBR-796 | C.H. Boehringer Sohn Ag & Co. Kg | Details | ||
| LY-3114062 | LY3114062; LY-3114062 | Eli Lilly And Company | Details | ||
| Tanfanercept | HBM-9036; HL-036 | Phase 3 Clinical | Hanall | Dry Eye Syndromes; Xerophthalmia | Details |
| Recombinant human anti-TNFα monoclonal antibody (Qilu Pharmaceutical) | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Arthritis, Rheumatoid; Spondylitis, Ankylosing | Details | |
| Recombinant anti-TNFα antibody (Shanghai Xiesheng Medicine) | Phase 1 Clinical | Shanghai Harmony Pharmaceutical Technology Co Ltd | Details | ||
| Adalimumab biosimilar (DZM Biotech) | Phase 1 Clinical | Dzm Biotech Ltd | Arthritis, Rheumatoid | Details | |
| Etanercept biosimilar (Suzhou Genemen Biotech) | BF-02; GM-02 | Phase 1 Clinical | Suzhou Genemen Biotech Co Ltd | Spondylitis, Ankylosing | Details |
| Recombinant human monoclonal antibody specific for human tumor necrosis factor (North China Pharmaceutical) | Phase 1 Clinical | North China Pharmaceutical Company Ltd | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis | Details | |
| Adalimumab biosimilar (Hetero Drugs) | Phase 3 Clinical | Hetero Drugs Ltd | Arthritis, Rheumatoid | Details | |
| Adalimumab biosimilar (Prestige BioPharma) | PBP-1502 | Phase 1 Clinical | Prestige BioPharma Ltd | Details | |
| Isomyosamine | MYMD-1 | Phase 2 Clinical | Mymd Pharmaceuticals Inc | Depression; Anxiety; Hashimoto Disease; Coronavirus Disease 2019 (COVID-19); Healthy Aging; Inflammation | Details |
| CC-11050 | CC-11050 | Phase 2 Clinical | Celgene Corp | HIV Infections; Lupus Erythematosus, Cutaneous; Tuberculosis | Details |
| Etanercept biosimilar (Clover Biopharmaceuticals) | SCB-808 | Phase 3 Clinical | Sichuan Sanyecao Bio-Pharmaceutical Co Ltd | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Thrombocytopenia | Details |
| Adalimumab biosimilar (Hualan Biological Engineering) | Phase 3 Clinical | Hualan Genetic Engineering Co Ltd | Spondylitis, Ankylosing; Psoriasis; Arthritis | Details | |
| Hemay007 | Hemay-007 | Phase 2 Clinical | Tianjin Hemay Bio-Tech Co Ltd | Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative | Details |
| Golimumab biosimilar (Bio-thera) | BAT-2506 | Phase 3 Clinical | Bio-Thera Solutions Ltd | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic; Arthritis | Details |
| Monoclonal Antibody (Mab) sB24M | Phase 1 Clinical | Swiss Biopharma Med GmbH | Pyoderma Gangrenosum; Pyoderma | Details | |
| Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Leukemia; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Solid tumours; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dyslipidemias; Leukemia, Myeloid, Acute; Melanoma | Details |
| Certolizumab (Intrexon) | AG-014 | Phase 1 Clinical | Intrexon Corporation | Inflammatory Bowel Diseases | Details |
| PM-1016 | PM1016; TILT-123 | Phase 2 Clinical | Tilt Biotherapeutics Ltd | Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Hepatocellular; Melanoma | Details |
| CC-10015 | CC-10015 | Phase 2 Clinical | Celgene Corp | Sarcoidosis; Multiple Myeloma; Lupus Erythematosus, Systemic | Details |
| Hemay-005 | Hemay-005 | Phase 3 Clinical | Hainan Hailing Chemipharma Corporation Ltd, Tianjin Hemay Pharmaceutical Co Ltd | Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Pulmonary Disease, Chronic Obstructive; Behcet Syndrome; Plaque psoriasis; Dermatitis, Atopic | Details |
| Adalimumab biosimilar(Incepta) | Phase 3 Clinical | Incepta Pharmaceuticals Ltd | Arthritis, Rheumatoid | Details | |
| IA-14069 | IA-14069 | Phase 1 Clinical | ILAb Co Ltd | Arthritis, Rheumatoid | Details |
| XTMAB-16 | XTMAB-16 | Phase 1 Clinical | Xentria Inc | Sarcoidosis | Details |
| EYS-606 | EYS-606 | Phase 2 Clinical | Eyevensys SAS | Uveitis | Details |
| Golimumab biosimilar( Alvotech) | Phase 1 Clinical | Alvotech Swiss Ag | Details | ||
| Guselkumab/Golimumab | JNJ-78934804 | Phase 2 Clinical | Janssen Research & Development Llc | Colitis, Ulcerative; Crohn Disease | Details |
| ND-009 | ND-009 | Phase 1 Clinical | Numab Therapeutics Ag, Tillotts Pharma Ag | Inflammation | Details |
| Adalimumab biosimilar (Oncobiologics) | ONS-3010 | Phase 3 Clinical | Outlook Therapeutics Inc | Psoriasis | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
